HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DSM Remodels Nutrition Business With Fundamental Piece – Cannabinoid Ingredients

Executive Summary

Royal DSM and Colorado’s Mile High Labs partner to provide companies in supplement, food and beverage sectors with ingredients to develop formulations with CBD and other cannabinoids. They initially are targeting the US and look to enter Canada, South America, Europe and Australia.

You may also be interested in...

Nutrition Business Drives DSM Results While Under Construction Into More Focused Groups

With latest results , Dutch firm notes its “Health, Nutrition & Bioscience (HNB) structure became effective” at the start of the year. Structure includes food and beverage and animal nutrition and health groups as well as human health, nutrition and care.

Royal DSM Fills Plate With Nutrition, Health And Bioscience, Plans To Slice Off Chemical Business

Sale is among options it’s considering for materials business, which is currently “managed largely on a standalone basis.” Its health, nutrition and bioscience segments account for 80% to 85% of total sales and will operate as individual business groups.

Arcadia Biosciences Bites Into Cannabinoid Market, Buys Firms From Rapper Jay-Z’s Company

Food ingredient firm Arcadia Biosciences acquired CBD supplements and coconut waters from rapper Jay-Z’s cannabis market holding company and is thinking about opportunities to expand into additional cannabinoid segments, including beverages.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts